We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NRSNW market cap is 1.85M. The company's latest EPS is USD -0.7335 and P/E is -0.16.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.38M | -3.64M | -3.48M | -6.75M | -3.29M |
| Net Income | -3.15M | -3.89M | -5.23M | 784k | -2.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.24M | -2.89M | -5.59M | -13.55M | -13.3M |
| Net Income | -1.22M | -2.83M | -4.04M | -12.34M | -11.28M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.71M | 5.34M | 7.87M | 5.39M | 3.18M |
| Total Liabilities | 2.09M | 2.45M | 9.41M | 5.58M | 5.05M |
| Total Equity | 5.62M | 2.89M | -1.55M | -196k | -1.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 955k | 779k | 11.43M | 7.71M | 3.18M |
| Total Liabilities | 37k | 120k | 2.43M | 2.09M | 5.05M |
| Total Equity | 918k | 659k | 9.01M | 5.62M | -1.87M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.59M | N/A | -4.08M | N/A | -8.45M |
| Investing | -3.54M | N/A | 3.52M | N/A | 3.65M |
| Financing | 3.7M | N/A | 4.1M | N/A | 3.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -582k | -695k | -1.54M | -7.59M | -8.45M |
| Investing | -26k | -9k | -17k | -3.54M | 3.65M |
| Financing | 1.42M | 508k | 11.9M | 3.7M | 3.9M |
| Market Cap | 1.85M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.7 |
| Price to Book Ratio | -0.98 |
| Dividend Yield | - |
| Shares Outstanding | 15.38M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.09 (46.67%) |
| Company Name | NeuroSense Therapeutics Ltd |
| Address |
medinat ha-yehudim street, 85 herzliya, center |
| Website | https://www.neurosense-tx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
